Synthesis, in vitro antimycobacterial evaluation and docking studies of some new 5,6,7,8-tetrahydropyrido[4′,3′:4,5]thieno[2,3- d ]pyrimidin-4(3 H )-one schiff bases-Reference-Cited by-同舟云学术

Synthesis, in vitro antimycobacterial evaluation and docking studies of some new 5,6,7,8-tetrahydropyrido[4′,3′:4,5]thieno[2,3- d ]pyrimidin-4(3 H )-one schiff bases

Published:2016-02 Issue:3 Volume:26 Page:836-840
ISSN:0960-894X
Container-title:Bioorganic & Medicinal Chemistry Letters
language:en
Short-container-title:Bioorganic & Medicinal Chemistry Letters

Author:

Narender Malothu,Jaswanth S. Bhandaru,Umasankar Kulandaivelu,Malathi Jojula,Raghuram Reddy Adidala,Umadevi K.R.,Dusthackeer A.V.N.,Venkat Rao Kaki,Raghuram R. Akkinepally

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference30 articles.

1. http://www.who.int/challenges/mdr/, MDR-TB 2014 update, WHO.

2. Tuberculosis

3. Application of Fragment Growing and Fragment Linking to the Discovery of Inhibitors ofMycobacterium tuberculosisPantothenate Synthetase

4. High throughput screening of a library based on kinase inhibitor scaffolds against Mycobacterium tuberculosis H37Rv

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unearthing phytochemicals as natural inhibitors for pantothenate synthetase in Mycobacterium tuberculosis: A computational approach;Frontiers in Pharmacology;2024-07-29

2. Five-membered ring fused pyrimidine-based derivatives and their biological properties;Fused Pyrimidine-Based Drug Discovery;2023

3. Synthesis, In vitro Antibacterial and Antimycobacterial Activity and Docking Study of Thieno(3,2-e)(1,2,4)triazolo(1,5-c)pyrimidines;Anti-Infective Agents;2022-08

4. In Vitro Anticancer Activity Screening of Novel Fused Thiophene Derivatives as VEGFR-2/AKT Dual Inhibitors and Apoptosis Inducers;Pharmaceuticals;2022-06-02

5. Luciferase Reporter Phage Assay for Anti Tuberculosis Screening: Current Status and Challenges;Bioscience Biotechnology Research Communications;2020-08-25